Background Criteria to assess the appropriateness of prescriptions might serve as a helpful guideline during professional training and in daily practice, with the aim to improve a patient's pharmacotherapy. Objective To create a comprehensive and structured overview of existing tools to assess inappropriate prescribing. Method Systematic literature search in Pubmed (1991Pubmed ( -2013. The following properties of the tools were extracted and mapped in a structured way: approach (explicit, implicit), development method (consensus technique, expert panel, literature based), focused patient group, health care setting, and covered aspects of inappropriate prescribing. Results The literature search resulted in 46 tools to assess inappropriate prescribing.Twenty-eight (61%) of 46 tools were explicit, 8 (17%) were implicit and 10 (22%) used a mixed approach. Thirty-six (78%) tools named older people as target patients and 10 (22%) tools did not specify the target age group. Four (8.5%) tools were designed to detect inappropriate prescribing in hospitalised patients, 9 (19.5%) focused on patients in ambulatory care and 6 (13%) were developed for use in long-term care. Twenty-seven (59%) tools did not specify the health care setting. Consensus methods were applied in the development of 19 tools (41%), the others were based on either simple expert panels (13; 28%) or on a literature search (11; 24%). For three tools (7%) the development method was not described. Conclusion This overview reveals the characteristics of 46 assessment tools and can serve as a summary to assist readers in choosing a tool, either for research purposes or for daily practice use.
Introduction
The appropriate prescription of medication should "maximise efficacy and safety, minimise cost, and respect patient's preferences" [1] . Choosing the most appropriate medication for each patient in order to achieve desired therapeutic outcomes is a challenge for healthcare professionals in their daily practice [2] . Criteria to assess the appropriateness of prescriptions and to improve a patient's pharmacotherapy might serve as a helpful guideline during professional training and on the job on a daily basis. In recent years, with inappropriate prescribing becoming an important public health concern, different tools to assess inappropriate prescribing have been developed and published. These tools show major differences in structure and content. They can be grouped roughly into implicit (judgement-based) and explicit (criterion-based) tools, and tools showing a combination of both approaches.
Explicit tools are usually developed from published reviews, expert opinions, and consensus techniques. These criterionbased tools are mostly drug-oriented and/or disease-oriented and can be applied with little or no clinical judgement [3] . Explicit criteria are generally used as rigid standards and neither address individual differences among patients, nor the complexity and appropriateness of entire medication regimens [2] . They need to be updated regularly to ensure their conclusiveness. Furthermore, each country has specific guidelines, standards and approved medications, which makes a countryspecific adaption of explicit criteria necessary. The advantages are the lower cost of application and a higher degree of fairness in ensuring a more equal care [4] .
Implicit tools are judgement-based, patient-specific, and consider the patient's entire medication regimen [2] . Implicit criteria often depend on the user's knowledge, experience and attitude. They can also take into account patients' preferences. However, they may be time-consuming and can have low reliability [3] .
The combination of both explicit and implicit criteria enables to link the advantages of each approach. Explicit guidelines serve as background to supply user's clinical judgement of patient's medication and implicit questions provide a patientspecific approach with mostly a small number of items.
Creating a valid tool for the assessment of the appropriateness of a medication requires adequate evidence. In areas of health care where higher levels of evidence (e.g. controlled trials) are missing, consensus techniques are useful methods to develop an evidence base. These group facilitation techniques were developed to explore the level of consensus among a group of experts, whereby consensus is reached by summarizing many opinions into a single, agreed-upon, refined opinion [5] . Combining expert opinions with evidence from the literature seems to be a good approach to create a valid, useful tool. Types of consensus techniques are the RAND appropriateness method, the Delphi technique and the nominal group technique (NGT). The RAND combines current scientific evidence with the opinion of elected experts. Panelists rate, meet for discussion and then re-rate issues of interest. The Delphi technique consists of multiple questionnaire rounds with feedback to the panelists between rounds and uses evidence-based literature as a basis but omits expert meetings. The NGT is widely used to generate and prioritize ideas but usually has no initial review of the current scientific literature [5] .
Several publications summarize and compare selected existing tools to assess the appropriateness of prescribing [2, [6] [7] [8] [9] [10] [11] , but a comprehensive overview is still missing. The existing publications either focus on specific patient groups or only show just a small comparison of the most popular tools. Therefore, the objective of this study is to provide a systematic literature search to create a comprehensive and structured overview of all existing tools. A mapping will highlight their characteristics and will allow a comparison of the structure and the content of these tools.
Methods
Pubmed database search included the time period from January 1, 1991, to March 19, 2013 The MESH term "Inappropriate prescribing" was introduced only in 2011. Prior to this, "inappropriate prescribing" was included in the broadly defined MESH term "Drug therapy". We limited the search to studies in adults. Articles must have been published in English or German. The database search was completed with a manual search from the reference lists of included articles. The reviewer (RT) assessed publications for eligibility by title and abstract screening. Each article showing uncertainty regarding inclusion or exclusion criteria was discussed between three of the authors (RT, CK, ML).
Inclusion and exclusion criteria
We included articles describing tools or computerised decision support systems to assess inappropriate prescribing, updated versions of already published tools and adaptations of an already published tool if its further development was based on new expert consensus.
We defined the following exclusion criteria: Tools restricted to specific therapeutic classes (e.g., benzodiazepines, antibiotics, etc.), or specific diseases, tools targeted to children, adaption of already published tools to computerised decision support systems, medication review techniques which did not use a tool, educational interventions to improve prescribing practice, validation studies of previously published tools, and general guidelines or recommendations to assess inappropriate prescribing.
Mapping of the tools
We grouped the tools in three main domains (explicit, implicit and mixed tools). In every domain tools were ordered according the strength of evidence of their development method (consensus technique, expert panel, literature based). To highlight the characteristics of the tools we listed all properties in a structured way. We categorised inappropriate prescribing Spinewine [3] into underprescribing, overprescribing and misprescribing and defined these terms as follows [12, 13] :
Underprescribing: The omission of a medication that is needed (no therapy for a given indication) Overprescribing: The prescription of a medication that is clinically not indicated (unnecessary therapy) Misprescribing: The incorrect prescription of an indicated medication.
We further divided misprescribing in:
-Drug choice: Better alternatives are available (better riskbenefit ratio or better cost-effectiveness) -Dosage: Prescribed dose too low or too high or not correctly adapted to patient characteristics (e.g. renal function, body weight.)
-Duration of therapy: Duration of therapy too long or too short -Duplication: Inappropriate prescription of drugs of the same pharmacological class -Drug-Disease, Drug-Drug, Drug-Food Interactions:
Combination of a drug with another drug, with food or with a medical condition with a potential or manifest negative impact on the therapeutic outcome
We listed the focused patient group (elderly, all age), and health care setting (hospital care, ambulatory care, long-term care). In addition, we added adherence, cost-effectiveness and whether the tool suggested alternative therapies to the inappropriate ones. The aspect of adherence represents, to a certain extent, the patients' preferences. Intentional non-adherence reflects patients' unwillingness to take their medication, mostly 
Results
A total of 716 articles was identified through database search. The numbers of included and excluded articles at each stage are displayed in a flowchart (see Fig. 1 ). In the end, 46 publications met the inclusion criteria and described 46 different tools. Twenty (43%) of the 46 tools were related to previously published tools (see Fig. 2 ).
Characteristics (see Table 1, 2 and 3) Twenty-eight (61%) of 46 tools were explicit, 8 (17%) were implicit and 10 (22%) used a mixed approach. Looking at the patient groups the tools focused on, thirty-six (78 %) tools named older people as target patients and 10 (22%) tools did not specify the target age group. Four (8.5 %) tools were designed to detect inappropriate prescribing in hospitalised patients, 9 (19.5%) focused on patients in ambulatory care and 6 (13%) were developed for use in long-term care. Twentyseven (59%) tools did not specify the health care setting. Consensus methods were applied in the development of 19 tools (41%; RAND 2, Delphi technique 16, Nominal group technique 1), the others were based on either simple expert panels (13, 28%) or on a literature search (11, 24%). For three tools (7%) the development method was not described [14] [15] [16] .
Aspects of inappropriate prescribing
The aspect of misprescribing was covered to a different extent by each tool. Fourteen (30%) tools focused on overprescribing, 6 (13%) on underprescribing, 8 (17%) mentioned nonadherence and 5 (11%) the cost-effectiveness. Fourteen (30%) tools offered alternative therapies.
Discussion
The rapidly growing number of publications about inappropriate prescribing demonstrates the increased interest in this topic over RD RAND method; Dp Delphi method; NGT Nominal group technique; Ex Expert panel; Lit based on literature research; El Elderly; L Patients in longterm care; H Hospitalized patients; A Ambulatory patients; ns not specified the last decade. Many attempts have been made to improve drug prescribing. Tools to achieve this aim are numerous, as we show in this overview, each with a different structure and degree of comprehensiveness and complexity. Many of them might serve as a useful aid to improve prescribing, but each tool has its limitations, strengths and weaknesses. In general, an ideal tool to assess the appropriateness of drug prescriptions should:
& cover all aspects of appropriateness (efficacy, safety, costeffectiveness and patients' preferences) & be developed using evidence-based methods & show significant correlation between the degree of inappropriateness and clinical outcomes & be applicable not only in research conditions but also in daily health care practice
None of the tools we describe in this systematic overview covers all aspects of inappropriate prescribing. In particular, underprescribing is only mentioned in 6 tools, although underprescribing represents an important aspect of inappropriate prescribing and is prevalent particularly in the elderly [17] . Many tools strongly emphasize the choice of a drug which leads to a better compliance with treatment guidelines. But respecting all relevant treatment guidelines without individualisation is in the best case rational prescribing but not necessarily appropriate prescribing [18] . Individualisation is therefore a prerequisite for Table 3 Tools with a mixed approach (explicit/implicit) to assess inappropriate prescribing •=Aspect totally covered by the criteria. ○=Aspect partially covered by the criteria Abbreviations:
RD RAND method; Dp Delphi method; NGT Nominal Group Technique; Ex Expert panel; Lit based on literature research; El Elderly; L Patients in long-term care; H Hospitalized patients; A Ambulatory patients; ns not specified appropriate prescribing and, thus, the drug-patient interaction is implicitly included in any aspect of appropriate prescribing.
The development methods of the tools we mapped varied a lot and ranged from those which included no information about any aspects of development, to those which used an intensive literature search combined with multiple consensus techniques.
The results obtained from the use of any of the tools represent process measures. Improving the patient's prescription according to such a tool does not necessarily improve outcomes (e.g. mortality, morbidity, adverse drug events, quality of life, etc.). Correlations between process measures and clinical outcomes should be demonstrated in welldesigned clinical trials. For the majority (39/46) of the tools we could not find such clinical validation in the literature.
In a systematic review, Spinewine et al. [3] analysed the correlation between the use of inappropriate medications according to the Beers Criteria [19] [20] [21] , the McLeod's Criteria [22] , and the Medication Appropriateness Index [23] and patient outcomes: Many studies examined the Beers Criteria and showed a significant correlation of potentially inappropriate medication (PIM) and negative clinical outcomes (e.g., mortality, adverse drug reactions, hospital admission). Additional studies not included in Spinewine's review showed evidence that minimizing inappropriate prescriptions may reduce negative patient outcomes (see Table 4 ).
Assessment tools are not intended as a substitute for the prescriber's careful clinical decision-making, even if they have been perfectly validated. Instead, when implemented in daily practice, they alert health care professionals to the likelihood of inappropriate prescribing [9] . Such implementation, however, requires that tools should not only be well designed and comprehensive, but also still practical in daily use. Integration of assessment tools in electronic decision support systems could be a promising approach [24] [25] [26] [27] . One tool, the BarenholtzLevy Medication Risk Questionnaire [28] is designed for selfassessment by the patient which represents a very different strategy.
A short description of each tool including the number of items, where assessable (cf. Table 1, 2 and 3), provides some information about the construction and complexity. The number of items per tool varies a lot and ranges from less than ten to more than a hundred items. However a direct relation between the number of items and the complexity of a tool is not clearly given. As an example: the implicit Medication Appropriateness Index (MAI) [23] consists of only 10 questions to patient's medication. But the application of the MAI requires clinical knowledge and is time intensive. On the other hand the explicit Beers Criteria [29] , with a high number of items, but arranged in a comprehensive way is easy to handle for a person who is used to it.
Limitations
The literature search was restricted to articles published in English and German; criteria published in other languages were reasonably not included because analysing and mapping the tools required a complete understanding of the text. Literature search, abstract and full text screening were done by only one of the authors (RT). Uncertainties were discussed by all authors. The mapping was developed by one author (RT) and reviewed by a second (CK). Uncertainties about eligibility of a study or classification of the tool were discussed by at least three authors.
Conclusion
Through a systematic literature search we identified 46 different tools to assess inappropriate prescribing showing a large variety in methodological aspects and in clinical validation. Not surprisingly with such a variety of tools in such a complex field, this overview could not identify a single ideal tool but may help readers to choose one, either for research purposes or for daily practice use, according to the situation in which it is intended to be applied. By outlining the characteristics in a highly structured manner, this overview may reveal strengths and weaknesses, and thus, may stimulate further research in this area.
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